CA996116A - Preparation of 5-(substituted phenoxy)-4-amino pyrimidines - Google Patents

Preparation of 5-(substituted phenoxy)-4-amino pyrimidines

Info

Publication number
CA996116A
CA996116A CA179,926A CA179926A CA996116A CA 996116 A CA996116 A CA 996116A CA 179926 A CA179926 A CA 179926A CA 996116 A CA996116 A CA 996116A
Authority
CA
Canada
Prior art keywords
preparation
substituted phenoxy
amino pyrimidines
pyrimidines
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA179,926A
Other languages
English (en)
Inventor
Christopher A. Lipinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of CA996116A publication Critical patent/CA996116A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA179,926A 1972-09-08 1973-08-29 Preparation of 5-(substituted phenoxy)-4-amino pyrimidines Expired CA996116A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US287423A US3862190A (en) 1972-09-08 1972-09-08 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines

Publications (1)

Publication Number Publication Date
CA996116A true CA996116A (en) 1976-08-31

Family

ID=23102839

Family Applications (1)

Application Number Title Priority Date Filing Date
CA179,926A Expired CA996116A (en) 1972-09-08 1973-08-29 Preparation of 5-(substituted phenoxy)-4-amino pyrimidines

Country Status (13)

Country Link
US (1) US3862190A (en:Method)
JP (1) JPS5543463B2 (en:Method)
AR (1) AR202106A1 (en:Method)
AU (1) AU471279B2 (en:Method)
BE (1) BE804414A (en:Method)
CA (1) CA996116A (en:Method)
CH (1) CH581121A5 (en:Method)
DE (1) DE2344611A1 (en:Method)
ES (1) ES418567A1 (en:Method)
FI (1) FI59796C (en:Method)
FR (1) FR2198753B1 (en:Method)
GB (1) GB1434805A (en:Method)
NL (1) NL7312270A (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941889A (en) * 1972-09-08 1976-03-02 Pfizer Inc. 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents
JPS57164686U (en:Method) * 1981-04-11 1982-10-16
JPS6197973U (en:Method) * 1984-12-03 1986-06-23
JPS63135868U (en:Method) * 1987-02-26 1988-09-06
WO1998014430A1 (fr) * 1996-10-02 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyrimidine
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) * 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
DE60142236D1 (de) * 2000-07-24 2010-07-08 Krenitsky Pharmaceuticals Inc Substituierte 5-alkinyl-pyrimidine mit neurotropher wirkung
US8895574B2 (en) 2010-12-24 2014-11-25 Nihon Nohyaku Co., Ltd. Benzyloxypyrimidine derivative, agricultural/ horticultural insecticide comprising derivative and method for using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB886693A (en) * 1959-03-04 1962-01-10 Ici Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
NL7312270A (en:Method) 1974-03-12
FI59796B (fi) 1981-06-30
JPS5543463B2 (en:Method) 1980-11-06
DE2344611A1 (de) 1974-03-14
AU6003173A (en) 1975-03-06
JPS4992080A (en:Method) 1974-09-03
CH581121A5 (en:Method) 1976-10-29
ES418567A1 (es) 1976-08-01
FI59796C (fi) 1981-10-12
AU471279B2 (en) 1976-04-15
FR2198753B1 (en:Method) 1976-09-03
FR2198753A1 (en:Method) 1974-04-05
BE804414A (fr) 1974-03-04
GB1434805A (en) 1976-05-05
AR202106A1 (es) 1975-05-15
US3862190A (en) 1975-01-21

Similar Documents

Publication Publication Date Title
AU475379B2 (en) Novel insecticidal composition
CA1010781A (en) Insecticidal composition
CA1033727A (en) Preparation of w-pentanorprostaglandins
CA1020554A (en) Preparation of thiocarbamylsulfenamides
CA996116A (en) Preparation of 5-(substituted phenoxy)-4-amino pyrimidines
CA989839A (en) 5-(3-iodopropargyloxy) pyrimidine
CA984579A (en) Preparation of 238pu16o2
CA999002A (en) Preparation of nitrophenylpyridines
AU472072B2 (en) Preparation of 3-fluoro-d-alanine
AU5242673A (en) Manufacture of pyrimidines
CA890398A (en) Pesticidal composition
CA1028701A (en) Preparation of thiocarbamylsulfenamides
CA907016A (en) Preparation of substituted phenoxyalkylamines
CA893087A (en) Insecticidal composition
AU477526B2 (en) Insecticidal composition
CA897594A (en) Insecticidal composition
CA905401A (en) Manufacture of bipyridylium salts and related compounds
CA915843A (en) Polymer-filler composition
CA899911A (en) Preparation of perchlorofluoropropanes
CA900491A (en) Preparation of tertiary-amino-substituted-alkylamines
AU488391B2 (en) Preparation of 2-nitro-4-amino-phenylaniline
CA916174A (en) Preparation of o-chlorophenols
AU477850B2 (en) Preparation of thiocarbamylsulfenamides
CA889866A (en) Preparation of methallylsilanes
CA892042A (en) Preparation of phenazine-di-n-oxides